Clinical Trial Update: Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether adding stereotactic body radiotherapy to standard of care improves outcomes for patients with cancer that has spr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Triple Negative Breast Cancer, Non Small Cell Lung Cancer | Phase 2 | Status: RECRUITING